Ombitasvir/paritaprevir/r, dasabuvir and sofosbuvir treatment of patients with genotype 1 infection who failed a prior course of DAA therapy: the QUARTZ-I study - Poordad, F; Bennett, M; Sepe, T E (J Hepatol, 2016)
, et al.